Enza biotech AB lund
are proud to announce that Enza Biotech is now part of Croda International Plc., a perfect partnership for bringing. We look forward to working with the Croda team and the new opportunities that will bring. It is a great fit as sustainability underpins our growth strategy and is an area that already sets us apart in the eyes of our customers. Publication # Title Filing Date Pub Date Intl Class 2016/0235,852, surfactant compositionsep 30, 14Aug 18, 16C11D, A61K. Recent Patents, no Recent Patents to Display, expired/Abandoned/Withdrawn Patents. The cross-disciplinary team behind Enza Biotech combines scientific excellence with industrial experience to bring to you the next generation of biobased surfactants. Enza Biotech was founded in 2012 by researchers at Lund University with the aim to develop the next generation of renewable surfactants using carbohydrate-based chemistry. This acquisition demonstrates Crodas commitment to delivering sustainable solutions without compromising on product performance as this novel range of surfactants has been proven to offer differentiated performance benefits across many applications, such as emulsification, wetting and dispersion.
The company is situated.
Lund, in Southern Sweden, with close links to the scientific environment.
Enza Biotech operates in the borderland between science and business, and sets out to become a key player in the transition from a fossil-dependent to a biobased society.
Enza Biotech AB, a biotechnology company, researches and develops renewable surfactants using carbohydrate-based chemistry. The company was founded in 2012 and is based. Enza biotech AB s, lund, SE, patent portfolio profile on Patent Buddy. Patent Buddy is the world s most extensive database and networking website for patent attorneys, agents and inventors helping inventors like.
Croda will also gain the expertise of Enza co-founders Maria Andersson and Stefan Ulvenlund, and their team, as they become full time employees to lead the commercialisation of their work using Crodas technical and formulation expertise, global operational footprint and sales force and track record. Details 0, issued Patents 0, issued in last 3 years 1, published in last 3 years 0, total Citation Count, sep 30, 2014. Read More, the oligomeric alkyl glycoside technology was presented at Formula viii. A61K, preparations FOR medical, dental, OR toilet purposes 1254. Oligomeric alkylglycosides have longer hydrophilic headgroups and are both less irritating and have improved functionalities. Enza Biotech was granted 300.000 SEK from Vinnova for developing their olmag surfactant platform. Existing Portfolios, create New Portfolio, user Portfolios, you have not yet added any portfolios.